Skip to main content

Table 2 Background regimens used in combination with bedaquiline

From: Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety

Drug

Patients (n = 1162), n (%)

Linezolid

1030 (88.6)

Cycloserine

962 (82.8)

Clofazimine

694 (59.7)

Protionamide

592 (50.9)

Amikacin

482 (41.5)

Moxifloxacin

467 (40.2)

Aminosalicylic acid

399 (34.3)

Pyrazinamide

293 (25.2)

Capreomycin

214 (18.4)

Levofloxacin

157 (13.5)

Ethambutol

132 (11.4)

Amoxicillin; clavulanate potassium

61 (5.2)

Pasiniazid

17 (1.5)

Isoniazid

14 (1.2)

Clarithromycin

8 (0.7)

Cilastatin; imipenem

1 (0.1)

Gatifloxacin

1 (0.1)

Meropenem

1 (0.1)

Rifabutin

1 (0.1)

Streptomycin

1 (0.1)

Terizidone

1 (0.1)